These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications. Dávila DF; Núñez TJ; Odreman R; de Dávila CA Int J Cardiol; 2005 Jun; 101(3):343-6. PubMed ID: 15907399 [TBL] [Abstract][Full Text] [Related]
17. [Responses to vasodilator therapy in patients with congestive heart failure]. Guo HY Sheng Li Ke Xue Jin Zhan; 1984 Jan; 15(1):30-4. PubMed ID: 6515395 [No Abstract] [Full Text] [Related]
18. Vasodilators and inotropic agents in the treatment of congestive heart failure. Francis GS Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651 [TBL] [Abstract][Full Text] [Related]
19. [Vasodilator agents in chronic heart failure: which is the best option?]. Corbalán R; Kunstmann S; Jalil J Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172 [TBL] [Abstract][Full Text] [Related]
20. [Effect of peripheral vasodilator agents on the state of the microcirculatory bed in congestive circulatory failure]. Sivkov II; Mukharliamov NM; Agababian IR Sov Med; 1987; (1):3-9. PubMed ID: 3563641 [No Abstract] [Full Text] [Related] [Next] [New Search]